Metabolix (MBLX) Reports Q3 Loss of $0.05/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Equities close higher as softer jobs data quiets rate-hike expectations
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Metabolix Announces Third Quarter 2016 Financial Results
November 9, 2016 4:06 PM ESTCAMBRIDGE, Mass., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ: MBLX), today reported financial results for the three months ended September 30, 2016.
We are excited to be moving forward focusing exclusively on the Yield10 Bioscience mission to address the challenge of global food security, said Oliver Peoples, Ph.D., president and chief executive officer. We sold and transferred our legacy biopolymer assets to CJ CheilJedang. In addition, we completed winding down biopolymer related activities and substantially completed the restructuring of the business. We recently announced the Yield10 management team, and we are now directing our... More
